Key Stats for UiPath Stock
- 1-day Price Change for UiPath stock: 6.5%
- Current Share Price: $13.38
- 52-Week High: $15.93
- $PATH Stock Price Target: $13.40
What Happened?
UiPath (PATH) stock surged nearly 7% on Tuesday after the company announced a wave of strategic partnerships with AI heavyweights, including Nvidia, OpenAI, Microsoft Azure, Snowflake, and Google Cloud.
The automation platform provider is positioning itself as the orchestration layer connecting different AI agents and models across enterprises.
UiPath will build a ChatGPT connector integrating OpenAI’s frontier models with enterprise workflows. The two companies are creating benchmarks for using computer-use models in agentic automation, making it easier to evaluate AI agent performance in real business scenarios.
ChatGPT Enterprise users will soon be able to view available UiPath automations directly within ChatGPT.
The Nvidia partnership addresses high-stakes use cases, such as fraud detection and healthcare workflows. UiPath is launching an Integration Service Connector linking its platform with Nvidia’s NIM microservices and Nemotron reasoning models.
This enables companies to deploy AI into sensitive processes with enterprise-grade governance and control, which is crucial for regulated industries that can’t afford black-box AI.
Microsoft announced the integration of UiPath with Azure AI Foundry, enabling customers to orchestrate workflows across both Microsoft and UiPath AI agents.
The partnership includes bi-directional integrations with Microsoft 365 Copilot and Copilot Studio. UiPath is now featured in Microsoft Marketplace’s new AI Apps and Agents category.
The Snowflake collaboration integrates UiPath’s automation platform with Snowflake Cortex AI, enabling customers to transform data insights into automated actions without overhauling their legacy systems.
Google Cloud’s partnership brings voice interaction to UiPath agents using Gemini models, allowing users to trigger automations through natural speech rather than typing or coding.
The company also introduced Maestro Case Management for orchestrating complex business cases, new pre-built solutions for financial services and healthcare, and enhanced tools for building and testing AI agents.
See analysts’ growth forecasts and price targets for UiPath stock (It’s free!) >>>
What the Market Is Telling Us About PATH Stock
PATH stock is surging on this news, indicating that investors believe UiPath has found its niche in the AI infrastructure stack.
UiPath aims to become the orchestration layer that connects different AI agents and automates end-to-end business processes.
Chief Product Officer Graham Sheldon made the strategy clear: “Enterprises don’t just need AI. They need it running inside the processes that matter most.”
Companies have dozens of disconnected AI tools and legacy systems, and UiPath promises to tie them together with governance, security, and auditability that enterprises require.
Companies are experimenting with autonomous agents that can complete tasks with minimal human oversight. However, these agents need to work together and integrate with existing systems, making orchestration critical.
Wall Street Analysts Are Bullish on These 5 Undervalued Compounders With Market-Beating Potential
TIKR just released a new free report on 5 compounders that appear undervalued, have beaten the market in the past, and could continue to outperform on a 1-5 year timeline based on analysts’ estimates.
Inside, you’ll get a breakdown of 5 high-quality businesses with:
- Strong revenue growth and durable competitive advantages
- Attractive valuations based on forward earnings and expected earnings growth
- Long-term upside potential backed by analyst forecasts and TIKR’s valuation models
These are the kinds of stocks that can deliver massive long-term returns, especially if you catch them while they’re still trading at a discount.
Whether you’re a long-term investor or just looking for great businesses trading below fair value, this report will help you zero in on high-upside opportunities.
Click here to sign up for TIKR and get our full report on 5 undervalued compounders completely free.
Looking for New Opportunities?
- See what stocks billionaire investors are buying so you can follow the smart money.
- Analyze stocks in as little as 5 minutes with TIKR’s all-in-one, easy-to-use platform.
- The more rocks you overturn… the more opportunities you’ll uncover. Search 100K+ global stocks, global top investor holdings, and more with TIKR.
Disclaimer:
Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!
